A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth - Bertin Instruments

    Scientific publications

    A novel small molecule hydroxamate preferentially inhibits HDAC6 activity and tumour growth

    M Kaliszczak1, S Trousil1, O Åberg1, M Perumal1, Q-D Nguyen1 and E O Aboagye*,1
    Sources: 1Comprehensive Cancer Imaging Centre, Department of Surgery and Cancer Faculty of Medicine, Imperial College London, Hammersmith Hospital, Room 240, MRC Cyclotron Building, Du Cane Road, London W12 0NN, UK
    British Journal of Cancer (2013), 1-9 | doi: 10.1038/bjc.2012.Environment

    Sample name

    Animal tissues (tumour xenograft mice)

    Kits

    CK14_2mL

    ANY QUESTIONS? CONTACT AN EXPERT

    Please fill in this form if you wish to contact our sales team or receive further information.

    My Account
    Forgot password ?

    Add a question !

    Add a question